Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Aselage Steve
Relationship:   Director
City:   Fremont
State:   CA
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   293,421    

Indirect Shares

  19,500      
Direct Value   $6,843,889    

Indirect Value

  $130,455      
Total Shares   312,921      
Total Value   $6,974,344      


Cti Biopharma Corporation
 $219,369 Biomarin Pharmaceutical Inc
 $5,231,829 Travere Therapeutics, Inc
 $982,888 Biocryst Pharmaceuticals Inc
 $409,803 Cti Biopharma Corporation
 $219,369 Biomarin Pharmaceutical Inc
 $5,231,829 Travere Therapeutics, Inc
 $982,888 Biocryst Pharmaceuticals Inc
 $409,803
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    4   
    5    

     Stock price went up :

    0   
    3    
     Stock price went down :
    4   
    2    
   
     Gain/Loss Ratio :
   -4.0   
   1.5   
     Percentage Gain/Loss :
   -31.1%
 62.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Cti Biopharma Corporation CTIC EVP, Global Commercial... 2005-06-30 24,133 2004-08-03 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Business Of... 2012-07-02 59,030 2006-04-28 0    Premium*  
            Travere Therapeutics, Inc TVTX Director 2022-05-11 146,919 2021-11-05 19,500    Premium*  
            Acer Therapeutics Inc ACER Director 2023-11-17 0 2017-09-19 0    Premium*  
            Biocryst Pharmaceuticals Inc BCRX Director 2023-06-13 63,339 2019-03-12 0    Premium*  
* Premium Members only  

Records found :    169         Free Registration Required For Full Results.    Limit: 25

Download
  Page 6 of 7
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-20 4 OE $0.00 $0 D/D 2,500 43,978 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-25 4 OE $17.33 $159,037 D/D 9,177 53,155 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-05-26 4 OE $17.33 $702,073 D/D 40,512 84,490 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-06-07 4 OE $0.00 $0 D/D 2,500 46,478 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2011-10-28 4 OE $14.39 $242,831 D/D 16,875 63,353 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2012-05-11 4 OE $14.39 $324,480 D/D 21,530 68,340 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2012-05-15 4 OE $17.33 $173,300 D/D 10,000 69,030 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2012-07-02 4 OE $17.54 $1,672,351 D/D 95,345 154,375 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-03-07 4 OE $6.00 $1,668 D/D 278 221,383 0 -
TVTX Travere Therapeutics, Inc Chief Executive Officer   •       •      –    2018-08-31 4 OE $8.70 $104,400 D/D 12,000 257,883 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-02-02 4 OE $10.09 $252,250 D/D 25,000 221,667 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-03-17 4 OE $16.23 $162,300 D/D 10,000 206,667 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-04-16 4 OE $16.23 $162,300 D/D 10,000 198,940 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-10-07 4 OE $16.23 $973,800 D/D 60,000 249,794 0 -
TVTX Travere Therapeutics, Inc Director   –       •      –    2021-11-05 4 OE $16.23 $162,300 D/D 10,000 171,794 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Ops   •       –      –    2006-11-29 4 S $17.23 $86,150 D/D (5,000) 2,829 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2007-08-10 4 S $20.21 $405,389 D/D (20,000) 4,895 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2007-09-14 4 S $22.40 $224,000 D/D (10,000) 4,895 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev   •       –      –    2008-03-03 4 S $38.00 $1,520,000 D/D (40,000) 32,034 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-05-02 4 S $37.75 $143,450 D/D (3,800) 44,865 0 -
BMRN Biomarin Pharmaceutical I... SVP, Global Commercial Dev.   •       –      –    2008-05-06 4 S $37.75 $611,550 D/D (16,200) 28,665 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-02 4 S $21.00 $210,000 D/D (10,000) 41,271 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-03 4 S $21.00 $210,000 D/D (10,000) 31,271 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-04 4 S $21.50 $107,500 D/D (5,000) 50,361 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Business Officer   •       –      –    2010-03-05 4 S $21.95 $140,831 D/D (6,416) 43,945 0 -

  169  Records found
  1   2   3   4   5   6  7      
  Page 6 of 7  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed